Suven Life Sciences net profit more than doubled at ₹36 crore in the third quarter ended December 31, 2013, compared with ₹7.8 crore in the year-ago period. Total revenue increased by 92 per cent to ₹120 crore from ₹62.8 crore. The growth in profit was due to pre-launch supplies of three products under the contract research and manufacturing services segment, the company said in a release. Suven’s scrip lost 0.89 per cent on the BSE to close at ₹78.10.
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.